381 related articles for article (PubMed ID: 35616212)
1. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
McCullough PA; Amin A; Pantalone KM; Ronco C
J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
[TBL] [Abstract][Full Text] [Related]
2. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
Nichols GA; Amitay EL; Chatterjee S; Steubl D
Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
[No Abstract] [Full Text] [Related]
3. Cardiorenal syndrome type 4: A study of cardiovascular diseases in chronic kidney disease.
H S; B S A; Moger V; Swamy M
Indian Heart J; 2017; 69(1):11-16. PubMed ID: 28228293
[TBL] [Abstract][Full Text] [Related]
4. Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4.
Edmonston D; Morris JD; Middleton JP
Adv Chronic Kidney Dis; 2018 Sep; 25(5):454-467. PubMed ID: 30309463
[TBL] [Abstract][Full Text] [Related]
5. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.
Jois P; Mebazaa A
Semin Nephrol; 2012 Jan; 32(1):26-30. PubMed ID: 22365159
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and 30-day readmissions for heart failure with reduced ejection fraction with cardiorenal syndrome: A National Cohort Study.
Shanah L; Mir T; Uddin MM; Hussain T; Parajuli T; Bhat Z
Int J Cardiol; 2023 Jan; 370():244-249. PubMed ID: 36328112
[TBL] [Abstract][Full Text] [Related]
7. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
Balint I; Vučak J; Bašić-Marković N; Klarić D; Šakić VA
Acta Med Croatica; 2016 Dec; 70(4-5):325-31. PubMed ID: 29087629
[TBL] [Abstract][Full Text] [Related]
8. Cardio-renal syndrome type 4: epidemiology, pathophysiology and treatment.
House AA
Semin Nephrol; 2012 Jan; 32(1):40-8. PubMed ID: 22365161
[TBL] [Abstract][Full Text] [Related]
9. Cardionephrology and cardiorenal disease in Italy: state of the art.
Di Lullo L; Bellasi A; Barbera V; Ronco C
Rev Cardiovasc Med; 2021 Sep; 22(3):563-572. PubMed ID: 34565060
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications.
Vervloet MG; de Jong HJ; Pander J; Overbeek JA
BMC Nephrol; 2023 Nov; 24(1):337. PubMed ID: 37957561
[TBL] [Abstract][Full Text] [Related]
11. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.
Rangaswami J; Bhalla V; Blair JEA; Chang TI; Costa S; Lentine KL; Lerma EV; Mezue K; Molitch M; Mullens W; Ronco C; Tang WHW; McCullough PA;
Circulation; 2019 Apr; 139(16):e840-e878. PubMed ID: 30852913
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal Syndrome.
Ricci Z; Romagnoli S; Ronco C
Crit Care Clin; 2021 Apr; 37(2):335-347. PubMed ID: 33752859
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of cardiorenal syndrome in patients with heart failure: potential therapeutic targets.
Takahama H; Kitakaze M
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H715-H721. PubMed ID: 28733448
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal Syndrome: An Important Subject in Nephrocardiology.
Hatamizadeh P
Cardiol Clin; 2021 Aug; 39(3):455-469. PubMed ID: 34247758
[TBL] [Abstract][Full Text] [Related]
15. The cardio-renal-metabolic connection: a review of the evidence.
Marassi M; Fadini GP
Cardiovasc Diabetol; 2023 Jul; 22(1):195. PubMed ID: 37525273
[TBL] [Abstract][Full Text] [Related]
16. Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Nevola R; Alfano M; Pafundi PC; Brin C; Gragnano F; Calabrò P; Adinolfi LE; Rinaldi L; Sasso FC; Caturano A
Rev Cardiovasc Med; 2022 Mar; 23(3):106. PubMed ID: 35345273
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study.
Maisons V; Halimi JM; Fauchier G; de Fréminville JB; Goin N; Gueguen J; Gatault P; Sautenet B; Angoulvant D; Herbert J; Bisson A; Ducluzeau PH; Fauchier L
Diabetes Metab; 2023 May; 49(3):101441. PubMed ID: 36931430
[TBL] [Abstract][Full Text] [Related]
18. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine.
Ronco C; Ronco F; McCullough PA
Rev Cardiovasc Med; 2017; 18(3):93-99. PubMed ID: 29111542
[TBL] [Abstract][Full Text] [Related]
19. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
Halimi JM; de Fréminville JB; Gatault P; Bisson A; Gueguen J; Goin N; Sautenet B; Maisons V; Herbert J; Angoulvant D; Fauchier L
Nephrol Dial Transplant; 2022 Nov; 37(12):2386-2397. PubMed ID: 35438794
[TBL] [Abstract][Full Text] [Related]
20. Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease.
Prastaro M; Nardi E; Paolillo S; Santoro C; Parlati ALM; Gargiulo P; Basile C; Buonocore D; Esposito G; Filardi PP
J Clin Ultrasound; 2022 Oct; 50(8):1110-1124. PubMed ID: 36218199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
